Picture of Insulet logo

PODD Insulet Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Insulet, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line16.84.6206418247
Depreciation
Deferred Taxes
Non-Cash Items12153.757.285.1193
Unusual Items
Other Non-Cash Items
Changes in Working Capital-264-2.5-191-17-23.2
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-68.1119146430569
Capital Expenditures-123-157-109-134-219
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Software Development Costs
Other Investing Cash Flow Items40-33.8-10.2-12.2-3.3
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-82.7-191-119-146-223
Financing Cash Flow Items-32.2-16.8-13.5-7.6-26.1
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities40.7-40.3-13.6-28.1-595
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-116-11714.5249-237